title: Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy.
abstract: A longitudinal study found that the incidence of gynecomastia in HIV-infected male patients treated with highly active antiretroviral therapy was 0.8/100 patient-years, with a prevalence of 2.8% in those treated for > or = 2 y. Even though the physiopathology remains unclear, this study suggests that gynecomastia should be monitored in these patients.
authors.affiliation: Department of Infectious Diseases, University Hospital of Dijon, France.
authors.forename: L
authors.initials: L
authors.lastname: Piroth
authors.forename: M
authors.initials: M
authors.lastname: Grappin
authors.forename: J M
authors.initials: JM
authors.lastname: Petit
authors.forename: M
authors.initials: M
authors.lastname: Buisson
authors.forename: M
authors.initials: M
authors.lastname: Duong
authors.forename: P
authors.initials: P
authors.lastname: Chavanet
authors.forename: H
authors.initials: H
authors.lastname: Portier
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D005602:France / Q000453:epidemiology; D006177:Gynecomastia / Q000139:chemically induced* / Q000453:epidemiology; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D015994:Incidence; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D015995:Prevalence